BackMolecular Pharmacology (USA), Overview

Molecular Pharmacology (USA), Intangible Assets

Latest intangible assets for MLPH: $0.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$0.00

Peer trimmed avg / median

Loading

Molecular Pharmacology (USA), Intangible Assets History

Loading

Molecular Pharmacology (USA), vs. peers: Intangible Assets Comparison

Loading

Molecular Pharmacology (USA), Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Molecular Pharmacology (USA), (MLPH) FAQ

Molecular Pharmacology (USA), (MLPH) currently reports a intangible assets of $0 as of September 2014. In the prior-year period, the figure was $0. Use the charts on this page to explore Molecular Pharmacology (USA),'s intangible assets history and peer comparisons.

Molecular Pharmacology (USA),'s intangible assets changed from $0 to $0 (period ending September 2014). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Molecular Pharmacology (USA), reported $0 in intangible assets as of September 2014. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Molecular Pharmacology (USA),, and consider following MLPH for alerts when major investors trade the stock.